Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Barbara P Yawn, Matthew L Mintz & Dennis E Doherty. (2021) GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 289-299.
Read now
Read now
Michael Hindelang, Florian Kirsch & Reiner Leidl. (2020) Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 20:1, pages 79-91.
Read now
Read now
Yong Suk Jo, Sung Kyoung Kim, Seoung Ju Park, Soo-Jung Um, Yong-Bum Park, Ki Suck Jung, Deog Kyeom Kim & Kwang Ha Yoo. (2019) Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 361-369.
Read now
Read now
Magnus Kentson, Per Leanderson, Petra Jacobson & Hans Lennart Persson. (2018) The influence of disease severity and lifestyle factors on the peak annual 25(OH)D value of COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1389-1398.
Read now
Read now
Yong Suk Jo, Ho Il Yoon, Deog Kyeom Kim, Chul-Gyu Yoo & Chang-Hoon Lee. (2018) Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 101-107.
Read now
Read now
M. Kentson, P. Leanderson, P. Jacobson & H. L. Persson. (2018) Oxidant status, iron homeostasis, and carotenoid levels of COPD patients with advanced disease and LTOT. European Clinical Respiratory Journal 5:1.
Read now
Read now
Hyun Lee, Byung Woo Jhun, Juhee Cho, Kwang Ha Yoo, Jin Hwa Lee, Deog Kyeom Kim, Jong Deog Lee, Ki-Suck Jung, Jung Yeon Lee & Hye Yun Park. (2017) Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3301-3310.
Read now
Read now
Kirill A Zykov & Svetlana I Ovcharenko. (2017) Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1125-1133.
Read now
Read now
Ricarda Mewes, Winfried Rief, Klaus Kenn, Jens Ried & Nikola Stenzel. (2016) Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD). Psychology & Health 31:4, pages 470-486.
Read now
Read now
Robert A Stockley. (2014) Biomarkers in chronic obstructive pulmonary disease: confusing or useful?. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 163-177.
Read now
Read now
Cristina Jácome, Alda Marques, Raquel Gabriel & Daniela Figueiredo. (2013) Chronic obstructive pulmonary disease and functioning: implications for rehabilitation based on the ICF framework. Disability and Rehabilitation 35:18, pages 1534-1545.
Read now
Read now
JinHee Kim, Chin Kook Rhee, Kwang Ha Yoo, Young Sam Kim, Sei Won Lee, Yong Bum Park, Jin Hwa Lee, YeonMok Oh, Sang Do Lee, Yuri Kim, KyungJoo Kim & HyoungKyu Yoon. (2013) The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 561-568.
Read now
Read now
Fran¸ois Maltais. (2013) Exercise and COPD: Therapeutic Responses, Disease-Related Outcomes, and Activity-Promotion Strategies. The Physician and Sportsmedicine 41:1, pages 66-80.
Read now
Read now
Richard L. ZuWallack & Linda Nici. (2012) Modifying the Course of Chronic Obstructive Pulmonary Disease: Looking Beyond the FEV1. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:6, pages 637-648.
Read now
Read now
Alvar Agustí, Juan J. Soler, Jesús Molina, María José Muñoz, Manuel García-Losa, Montserrat Roset, Paul W. Jones & Xavier Badia. (2012) Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations?. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:5, pages 492-498.
Read now
Read now
Len Fromer. (2011) Diagnosing and treating COPD: understanding the challenges and finding solutions. International Journal of General Medicine 4, pages 729-739.
Read now
Read now
Christine Garvey, Len Fromer, Dennis F. Saver & Barbara P. Yawn. (2010) Pulmonary Rehabilitation: An Underutilized Resource in Primary COPD Care. The Physician and Sportsmedicine 38:4, pages 54-60.
Read now
Read now
Sally Spencer. (2009) Health status measurement in exacerbations of COPD. Expert Review of Respiratory Medicine 3:6, pages 573-583.
Read now
Read now
Articles from other publishers (72)
Jae Yeol Kim, Jae-Woo Jung, Min-Jong Kang, Deog Kyeom Kim, Hayoung Choi, Young-Jae Cho, Seung Hun Jang, Chang-Hoon Lee, Yeon Mok Oh & Ji Sook Park. (2023) The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study. The Korean Journal of Internal Medicine 38:5, pages 714-724.
Crossref
Crossref
Konstantinos Kostikas, Athena Gogali & Georgios Hillas. (2023) Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification. American Journal of Respiratory and Critical Care Medicine 208:4, pages 502-504.
Crossref
Crossref
Yan Wang, Limin Chai, Yuqian Chen, Jin Liu, Qingting Wang, Qianqian Zhang, Yuanjie Qiu, Danyang Li, Huan Chen, Nirui Shen, Xiangyu Shi, Jian Wang, Xinming Xie & Manxiang Li. (2023) Quantitative CT parameters correlate with lung function in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Frontiers in Surgery 9.
Crossref
Crossref
思佚 刘. (2023) Progress of Pulmonary Function and Quantitative CT Studies of AECOPD in Middle and High Altitude Areas. Advances in Clinical Medicine 13:06, pages 9886-9891.
Crossref
Crossref
Kyeung Eun Lim, Sung Reul Kim, Hye Young Kim, So Ri Kim & Yong Chul Lee. (2022) Self‐management model based on information–motivation–behavioral skills model in patients with chronic obstructive pulmonary disease. Journal of Advanced Nursing 78:12, pages 4092-4103.
Crossref
Crossref
Tai Joon An, Chin Kook Rhee, Yong Bum Park, Kwang-Ha Yoo & Hyoung Kyu Yoon. (2022) FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap. Scientific Reports 12:1.
Crossref
Crossref
Shuen Yee Lee, Ma Shwe Zin Nyunt, Qi Gao, Xinyi Gwee, Denise Qian Ling Chua, Keng Bee Yap, Shiou Liang Wee & Tze Pin Ng. (2022) Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality. Chest 161:5, pages 1225-1238.
Crossref
Crossref
Çağla Koç & Füsun Şahin. (2022) What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?. Medicina 58:2, pages 163.
Crossref
Crossref
Bo-Guen Kim, Sun Hye Shin, Hyun-Il Gil, Sungmin Zo, Yunjoo Im, Ju Yeun Song, Chai Young Lee, Danbee Kang, Juhee Cho & Hye Yun Park. (2022) Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease. Therapeutic Advances in Chronic Disease 13, pages 204062232211142.
Crossref
Crossref
Hui Yu, Jing Zhao, Dongyi Liu, Zhen Chen, Jinglai Sun & Xiaoyun Zhao. (2021) Multi-channel lung sounds intelligent diagnosis of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Juwhan Choi, Jae Kyeom Sim, Jee Youn Oh, Young Seok Lee, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Chin Kook Rhee & Kyung Hoon Min. (2021) Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (DLCO) and forced expiratory volume in one second (FEV1). BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Dong-Hyun Joo, Kyoung-Hee Lee, Chang-Hoon Lee, Jisu Woo, Jiyeon Kim, Seoung Ju Park, Chin Kook Rhee, Won-Yeon Lee, Dongil Park, Jae Seung Lee, Ki-Suck Jung, Kwang Ha Yoo & Chul-Gyu Yoo. (2021) Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease. Respiratory Research 22:1.
Crossref
Crossref
Jens T. Bakker, Karin Klooster, Rozemarijn Vliegenthart & Dirk-Jan Slebos. (2021) Measuring pulmonary function in COPD using quantitative chest computed tomography analysis. European Respiratory Review 30:161, pages 210031.
Crossref
Crossref
Sotirios Kakavas, Ourania S. Kotsiou, Fotis Perlikos, Maria Mermiri, Georgios Mavrovounis, Konstantinos Gourgoulianis & Ioannis Pantazopoulos. (2021) Pulmonary function testing in COPD: looking beyond the curtain of FEV1. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Leah J. Witt, W. Alexandra Spacht, Kyle A. Carey, Vineet M. Arora, Steven R. White, Megan Huisingh-Scheetz & Valerie G. Press. (2021) Weak Handgrip at Index Admission for Acute Exacerbation of COPD Predicts All-Cause 30-Day Readmission. Frontiers in Medicine 8.
Crossref
Crossref
Yingmeng Ni, Youchao Yu, Ranran Dai & Guochao Shi. (2021) Diffusing capacity in chronic obstructive pulmonary disease assessment: A meta-analysis. Chronic Respiratory Disease 18, pages 147997312110563.
Crossref
Crossref
Ahmed Virani, Stephanie Baltaji, Meilin Young, Tiffany Dumont & Tariq Cheema. (2021) Chronic Obstructive Pulmonary Disease. Critical Care Nursing Quarterly 44:1, pages 9-18.
Crossref
Crossref
Arschang Valipour, Sebastian Fernandez-Bussy, Alvin J. Ing, Daniel P. Steinfort, Gregory I. Snell, Jonathan P. Williamson, Tajalli Saghaie, Louis B. Irving, Eli J. Dabscheck, William S. Krimsky & Jonathan Waldstreicher. (2020) Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine 202:5, pages 681-689.
Crossref
Crossref
Claus F. Vogelmeier & Peter Alter. (2020) Assessing Symptom Burden. Clinics in Chest Medicine 41:3, pages 367-373.
Crossref
Crossref
Yeon Wook Kim, Chang-Hoon Lee, Hun-Gyu Hwang, Yu-Il Kim, Deog-Kyeom Kim, Yeon-Mok Oh, Sang Haak Lee, Ki Uk Kim & Sang-Do Lee. (2020) Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:5, pages 1512.
Crossref
Crossref
K. A. Zykov, S. I. OvcharenkoS. N. AvdeevA. V. Zhestkov, M. M. Il'kovich, V. A. Nevzorova, U. R. Farkhutdinov, R. F. Khamitov, A. V. Rvacheva & A. G. Chuchalin. (2020) Phenotypic characteristics of COPD patients with a smoking history in POPE-study in the Russian Federation. Russian Pulmonology 30:1, pages 42-52.
Crossref
Crossref
Sangita Kamath, Avesh Kumar, SumanKumar Panda & RudraPrasad Samanta. (2020) Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients – A prospective study. Journal of Family Medicine and Primary Care 9:11, pages 5606.
Crossref
Crossref
Noriyuki Ohkura, Kazuo Kasahara, Satoshi Watanabe, Johsuke Hara, Miki Abo, Takashi Sone, Hideharu Kimura, Munehisa Takata, Masaya Tamura, Isao Matsumoto, Yusuke Nakade, Shigeru Sanada & Rie Tanaka. (2020) Dynamic-Ventilatory Digital Radiography in Air Flow Limitation: A Change in Lung Area Reflects Air Trapping. Respiration 99:5, pages 382-388.
Crossref
Crossref
N. Jung, W.-J. Mayet, P.R. Mertens, J. Meyer (federführend)O.-A. Müller, M. Pfeifer, P. Schellinger, N. Weiss & C.-M. Wendtner. 2020. Rationelle Diagnostik und Therapie in der Inneren Medizin. Rationelle Diagnostik und Therapie in der Inneren Medizin
C-1
C22-4
.
Aparna Balasubramanian, Neil R. MacIntyre, Robert J. Henderson, Robert L. Jensen, Gregory Kinney, William W. Stringer, Craig P. Hersh, Russell P. Bowler, Richard Casaburi, MeiLan K. Han, Janos Porszasz, R. Graham Barr, Barry J. Make, Robert A. Wise & Meredith C. McCormack. (2019) Diffusing Capacity of Carbon Monoxide in Assessment of COPD. Chest 156:6, pages 1111-1119.
Crossref
Crossref
Kelly M. Dumais, Nadeeka Dias, Laura Khurana, Sarah Tressel Gary, Brooke Witherspoon, Christopher J. Evans & Susan M. Dallabrida. (2019) Preferences for Use and Design of Electronic Patient-Reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease. The Patient - Patient-Centered Outcomes Research 12:6, pages 621-629.
Crossref
Crossref
Heather M. Young, Rachel L. Eddy & Grace Parraga. (2019) MRI and CT lung biomarkers: Towards an in vivo understanding of lung biomechanics. Clinical Biomechanics 66, pages 107-122.
Crossref
Crossref
Konstantinos Kostikas, Timm Greulich, Alexander J. Mackay, Nadine S. Lossi, Maryam Aalamian-Mattheis, Xavier Nunez, Veronica A. Pagano, Francesco Patalano, Andreas Clemens & Claus F. Vogelmeier. (2019)
Treatment response in COPD: does FEV
1
say it all? A
post hoc
analysis of the CRYSTAL study
. ERJ Open Research 5:1, pages 00243-2018.
Crossref
Crossref
Shayan Mostafaei, Anoshirvan Kazemnejad, Sadegh Azimzadeh Jamalkandi, Soroush Amirhashchi, Seamas C. Donnelly, Michelle E. Armstrong & Mohammad Doroudian. (2018) Identification of Novel Genes in Human Airway Epithelial Cells associated with Chronic Obstructive Pulmonary Disease (COPD) using Machine-Based Learning Algorithms. Scientific Reports 8:1.
Crossref
Crossref
Ahsan Rao, Alex Bottle, Collin Bicknell, Ara Darzi & Paul Aylin. (2018) Trajectory Modelling to Assess Trends in Long-Term Readmission Rate among Abdominal Aortic Aneurysm Patients. Surgery Research and Practice 2018, pages 1-10.
Crossref
Crossref
Zubair Luqman & Rakesh C. Arora. (2018) “It's not easy being wheezy”. The Journal of Thoracic and Cardiovascular Surgery 156:4, pages 1552-1553.
Crossref
Crossref
Francisco Belchi, Mariam Pirashvili, Joy Conway, Michael Bennett, Ratko Djukanovic & Jacek Brodzki. (2018) Lung Topology Characteristics in patients with Chronic Obstructive Pulmonary Disease. Scientific Reports 8:1.
Crossref
Crossref
Magno F Formiga, Isabel Vital, Gisel Urdaneta, Kira Balestrini, Lawrence P Cahalin & Michael A Campos. (2018) The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications. SAGE Open Medicine 6, pages 205031211881901.
Crossref
Crossref
David Lowes, Khaled Al-Shair, Pippa J. Newton, Julie Morris, Chris Harris, Riina Rautemaa-Richardson & David W. Denning. (2017) Predictors of mortality in chronic pulmonary aspergillosis. European Respiratory Journal 49:2, pages 1601062.
Crossref
Crossref
M. Kirby. 2017. Hyperpolarized and Inert Gas MRI. Hyperpolarized and Inert Gas MRI
71
88
.
Jungsil Lee, Choon-Taek Lee, Jae Ho Lee, Young-Jae Cho, Jong Sun Park, Yeon-Mok Oh, Sang-Do Lee & Ho Il Yoon. (2016) Graphic analysis of flow-volume curves: a pilot study. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Carlos H. Martinez, Alejandro A. Diaz, Amit D. Parulekar, Stephen I. Rennard, Richard E. Kanner, Nadia N. Hansel, David Couper, Kristen E. Holm, Karin F. Hoth, Jeffrey L. Curtis, Fernando J. Martinez, Nicola A. Hanania, Elizabeth A. Regan, Robert PaineIIIIII, Christine T. Cigolle & MeiLan K. Han. (2016) Age-Related Differences in Health-Related Quality of Life in COPD. Chest 149:4, pages 927-935.
Crossref
Crossref
Eric A. Hoffman, David A. Lynch, R. Graham Barr, Edwin J.R. van Beek & Grace Parraga. (2016) Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. Journal of Magnetic Resonance Imaging 43:3, pages 544-557.
Crossref
Crossref
Dante P. I. Capaldi, Rachel L. Eddy & Grace Parraga. 2018. MRI of the Lung. MRI of the Lung
453
478
.
Yewon Kim, Kyungyong Jung, Ji Young Ryu, Dae Hwan Kim & Sangyoon Lee. (2015) A case of fitness to work in a worker with COPD using the exercise stress test. Annals of Occupational and Environmental Medicine 27:1.
Crossref
Crossref
Maggie Tabberer, Jean Brooks & Teresa Wilcox. (2015) A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Sujin Cho, Hochang Kim, Seon-Ha Kim, Minsu Ock, Yeon-Mok Oh & Min-Woo Jo. (2015) Utility estimation of hypothetical chronic obstructive pulmonary disease health states by the general population and health professionals. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Laura Fregonese. 2015. Imaging. Imaging
233
252
.
Wei-Chang Huang, Ming-Feng Wu, Hui-Chen Chen & Jeng-Yuan Hsu. (2015) Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study. npj Primary Care Respiratory Medicine 25:1.
Crossref
Crossref
Ji Young Hong, Song Yee Kim, Kyung Soo Chung, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Ae Kang, Se Kyu Kim, Joon Chang & Young Sam Kim. (2015) Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D. Quality of Life Research 24:10, pages 2549-2558.
Crossref
Crossref
Lorcan McGarvey. (2015) Keeping up appearances: the importance of maintaining health status in COPD. Thorax 70:9, pages 813-814.
Crossref
Crossref
Thomas M. Siler, Edward Kerwin, Ana R. Sousa, Alison Donald, Rehan Ali & Alison Church. (2015) Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies. Respiratory Medicine 109:9, pages 1155-1163.
Crossref
Crossref
Leena E. Tuomisto, Pinja Ilmarinen & Hannu Kankaanranta. (2015) Prognosis of new-onset asthma diagnosed at adult age. Respiratory Medicine 109:8, pages 944-954.
Crossref
Crossref
Claire Rooney & Tariq Sethi. (2015) Biomarkers for precision medicine in airways disease. Annals of the New York Academy of Sciences 1346:1, pages 18-32.
Crossref
Crossref
Sun Mi Choi, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Jae-Joon Yim, Young Whan Kim, Sung Koo Han & Chul-Gyu Yoo. (2015) Prevalence and Global Initiative for Chronic Obstructive Lung Disease Group Distribution of Chronic Obstructive Pulmonary Disease Detected by Preoperative Pulmonary Function Test. PLOS ONE 10:1, pages e0115787.
Crossref
Crossref
SamirKumar Sarkar, Sumitra Basuthakur, SibesK Das, Anirban Das, Soumya Das, Sabyasachi Choudhury & Samadarshi Datta. (2015) Evaluation of correlation of BODE index with health-related quality of life among patients with stable COPD attending a tertiary care hospital. Lung India 32:1, pages 24.
Crossref
Crossref
F. Rodrigues, I. Matias, J. Oliveira, S. Vacas & A. Botelho. 2015. Theory and Practice of Risk Assessment. Theory and Practice of Risk Assessment
133
146
.
Seon-Ha Kim, Yeon Mok Oh & Min-Woo Jo. (2014) Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health and Quality of Life Outcomes 12:1.
Crossref
Crossref
Carlos H Martinez, Marilyn L Moy, Huong Q Nguyen, Miriam Cohen, Reema Kadri, Pia Roman, Robert G Holleman, Hyungjin Myra Kim, David E Goodrich, Nicholas D Giardino & Caroline R Richardson. (2014) Taking Healthy Steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based internet-mediated walking program in veterans with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
François Chabot, Maeva Zysman, Julie Perrin, Magalie Mercy, Anne Guillaumot, Emmanuel Gomez, Ayman Kheir & Ari Chaouat. (2014) Impact de la BPCO : du handicap aux exacerbations. La Presse Médicale 43:12, pages 1353-1358.
Crossref
Crossref
A. Klemmer, T. Greulich, A. R. Koczulla & C. F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD). CME 11:12, pages 52-61.
Crossref
Crossref
K. Suresh Babu, Jack A. Kastelik & Jaymin B. Morjaria. (2014) Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective. British Journal of Clinical Pharmacology 78:2, pages 282-300.
Crossref
Crossref
Mark T. Dransfield, Gregory Feldman, Phillip Korenblat, Craig F. LaForce, Nicholas Locantore, Massimo Pistolesi, Michael L. Watkins, Courtney Crim & Fernando J. Martinez. (2014) Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respiratory Medicine 108:8, pages 1171-1179.
Crossref
Crossref
Harvey O. Coxson, Jonathon Leipsic, Grace Parraga & Don D. Sin. (2014)
Using Pulmonary Imaging to Move Chronic Obstructive Pulmonary Disease beyond FEV
1
. American Journal of Respiratory and Critical Care Medicine 190:2, pages 135-144.
Crossref
Crossref
A. Klemmer, T. Greulich, A.R. Koczulla & C.F. Vogelmeier. (2014) Die chronisch-obstruktive Lungenerkrankung (COPD)Chronic obstructive pulmonary disease (COPD). Der Internist 55:4, pages 401-414.
Crossref
Crossref
Yongping Gao, Qi Hou & Haoyan Wang. (2013) Assessment of Health Status in Patients with Newly Diagnosed Chronic Obstructive Pulmonary Disease. PLoS ONE 8:12, pages e82782.
Crossref
Crossref
Teresa K Wilcox, Wen-Hung Chen, Kellee A Howard, Ingela Wiklund, Jean Brooks, Michael L Watkins, Charlotte E Cates, Maggie M Tabberer & Courtney Crim. (2013) Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 11:1, pages 196.
Crossref
Crossref
Elvis M. Irusen. (2012) Deciphering the new global initiative for chronic obstructive lung disease (GOLD) guideline. Current Respiratory Care Reports 1:3, pages 183-188.
Crossref
Crossref
Tai Sun Park, Jae Seung Lee, Joon Beom Seo, Yoonki Hong, Sei Won Lee, Yeon-Mok Oh & Sang-Do Lee. (2012) Phenotyping of chronic obstructive pulmonary disease: heterogeneity and its clinical relevance. Current Respiratory Care Reports 1:3, pages 189-198.
Crossref
Crossref
Kevin Gruffydd-Jones. (2012) GOLD guidelines 2011: what are the implications for primary care?. Primary Care Respiratory Journal 21:4, pages 437-441.
Crossref
Crossref
Tomoaki Hoshino, Ryo Hirai & Yuzuru Inoue. (2012) 1. Pulmonary Function Test for COPD Diagnosis. Nihon Naika Gakkai Zasshi 101:6, pages 1543-1548.
Crossref
Crossref
MeiLan K. Han, Douglas Curran-Everett, Mark T. Dransfield, Gerard J. Criner, Lening Zhang, James R. Murphy, Nadia N. Hansel, Dawn L. DeMeo, Nicola A. Hanania, Elizabeth A. Regan, Barry J. Make, Fernando J. Martinez, Gloria E. Westney & Marilyn G. Foreman. (2011) Racial Differences in Quality of Life in Patients With COPD. Chest 140:5, pages 1169-1176.
Crossref
Crossref
Marc Miravitlles. (2011) Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respiratory Medicine 105:8, pages 1118-1128.
Crossref
Crossref
Tsiligianni Ioanna, Janwillem Kocks, Nikolaos Tzanakis, Nikolaos Siafakas & Thys van der Molen. (2011) Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations. Primary Care Respiratory Journal 20:3, pages 257-268.
Crossref
Crossref
Thomas Glaab & Christian Taube. (2011) Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 24:1, pages 15-22.
Crossref
Crossref
Renata Ferrari, Suzana E Tanni, Laura MO Caram, Cristiane R Naves & Irma Godoy. (2011) Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 9:1, pages 112.
Crossref
Crossref
Thomas Glaab, Claus Vogelmeier & Roland Buhl. (2010) Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respiratory Research 11:1.
Crossref
Crossref